The Oxford, UK-based Orbit Discovery, a privately held biopharmaceutical company focused on discovering candidate peptide therapeutics harnessing proprietary affinity and cell-based functional screening platforms, has raised US$7.6 million in funding.
Eli Lilly and Company and their industry partners, including sample management specialists – Ziath, are speeding the discovery of new medicines through the fully automated Lilly Life Sciences Studio (L2S2) lab in San Diego, USA
Porvair Sciences has installed new automated precision die-cutting equipment that has enabled a five-fold increase in its production capacity for porous plastic components.
A group of philanthropic funds and investors led by the Soros Economic Development Fund (SEDF), with support from the Bill & Melinda Gates Foundation, has launched Global Access Health (GAH), a social enterprise that will seek to expand access to affordable state-of-the-art medical technology through decentralized research, development, and manufacturing in and for the Global […]
CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures singleand multi-organ microphysiological systems (MPS), has secured the licensing rights to a novel tool for modelling the gut microbiome, GuMI, from Massachusetts Institute of Technology (MIT) and Northeastern University.
Biotium, a leading provider of reagents for immunofluorescence microscopy, is significantly expanding its line of antifade wet-set and hardset EverBrite Mounting
Amgen will acquire Teneobio, a privately held, clinical stage biotechnology company developing a new class of biologics called Human Heavy-Chain Antibodies.
Plasma volume status is vital in testing critically ill patients but is extremely difficult and costly to obtain, particularly as a POC test. Plasma volume assessment affects almost every aspect of a patient’s care, including giving IV fluids, diuresing, starting vasopressors, initiating renal replacement therapy, deciding on transfusion requirements and intubation and extubation.1,2
All start-ups that want to participate in this year’s 10th MEDICA Start-up Competition by submitting innovations can send in their application free of charge until 22 September 2021. For more information about the competition, visit: https://www.medica-tradefair.com/mac2
In addition to these highlights, a programme of several on-stage events at the epicentre of the trade fair will also be on offer. Holders of the relevant tickets can follow the talks and discussions simultaneously via livestreams on the industry portals MEDICA.de and COMPAMED.de.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
